Results 241 to 250 of about 44,494 (287)
Transforming the Indian Private Sector for Universal Health Coverage. [PDF]
Mor N.
europepmc +1 more source
ABSTRACT This study investigates the impact of greenhouse gas (GHG) emissions, research and development (R&D) spending, and cost leadership strategies (CLSs) on the environmental, social, and governance (ESG) performance of Asian firms from 2015 to 2023.
Mirza Muhammad Naseer +3 more
wiley +1 more source
Comparative Pharmacovigilance Analysis of Approved and Repurposed Antivirals for COVID-19: Insights from EudraVigilance Data. [PDF]
Negru PA +5 more
europepmc +1 more source
This retrospective cohort study indicates that patients with Kikuchi–Fujimoto disease demonstrated immunosuppression characterized by decreased counts of circulating CD3+ and CD4+ lymphocytes. Moreover, serum ferritin levels were inversely correlated with CD4+ lymphocyte counts, suggesting a potential role of ferritin in immune dysregulation in Kikuchi–
Peng Zhong +3 more
wiley +1 more source
Abstract We analyze Interferometric Synthetic Aperture Radar (InSAR) and Global Navigation Satellite System (GNSS) data to characterize ground deformation and dike opening associated with the May 2021 Nyiragongo eruption. Despite documented eruptions in 1977 and 2002, Nyiragongo's magmatic system and its interaction with regional rifting remain poorly ...
D. Murekezi +9 more
wiley +1 more source
A cap-dependent endonuclease inhibitor acts as a potent antiviral agent against La Crosse virus infection. [PDF]
Konishi K +9 more
europepmc +1 more source
When HEV infection meets organ transplantation. [PDF]
Ji C +6 more
europepmc +1 more source
Interferon Lambda: The Next Frontier in Antiviral Therapy? [PDF]
Chronopoulou S, Tsochantaridis I.
europepmc +1 more source
Treating Adenovirus Infection in Transplant Populations: Therapeutic Options Beyond Cidofovir? [PDF]
Narsana N, Ha D, Ho DY.
europepmc +1 more source
Screening of the Pandemic Response Box Library Identified CRM1/XPO1 as an Anti-Mammarenavirus Druggable Target. [PDF]
Ofodile CA +5 more
europepmc +1 more source

